Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Adenosquamous × Chemoradiotherapy × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 8 Uterine Cervical Dysplasia 1 Neoadjuvant Chemotherapy 1 Lymphatic Metastasis 1 Locally Advanced Cervical Cancer 1 Carcinoma, Adenosquamous 1 Adenocarcinoma 1

Interventions

pembrolizumab 1 fluoroazomycin arabinoside 1 cabozantinib 1 Metformin 1 Hysterectomy 1 Cisplatin 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01365156 2021-02-03

Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix

M.D. Anderson Cancer Center

Phase 3 Completed

28 enrolled 8 charts

Adenocarcinoma, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡